| |
| |
|
| Insider
Information: |
Esber Henry Jemil |
| Relationship: |
Director |
| City: |
West Boylston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
609,217 |
|
|
Indirect Shares
|
455,540 |
|
|
| Direct
Value |
$64,760 |
|
|
|
Indirect Value
|
$48,424 |
|
|
| Total
Shares |
1,064,757 |
|
|
| Total
Value |
$113,184 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seelos Therapeutics Inc |
SEEL |
Director |
2012-01-03 |
609,217 |
2010-12-14 |
455,540 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2012-01-03 |
4 |
A |
$5.13 |
$12,851 |
D/D |
2,505 |
609,217 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2011-09-30 |
4 |
A |
$3.58 |
$8,968 |
D/D |
2,505 |
606,712 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2011-07-01 |
4 |
A |
$3.55 |
$8,890 |
D/D |
2,505 |
543,877 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2011-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
60,330 |
604,207 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2011-05-16 |
4 |
A |
$3.55 |
$8,890 |
D/D |
2,505 |
541,372 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2010-12-14 |
4 |
A |
$0.00 |
$0 |
I/I |
73,670 |
455,540 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2010-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
83,327 |
538,867 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2010-06-21 |
4 |
A |
$2.52 |
$302,080 |
I/I |
119,873 |
192,412 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2010-06-21 |
4 |
A |
$2.52 |
$589,055 |
D/D |
233,752 |
381,870 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2010-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
2,221,760 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2010-03-15 |
4 |
A |
$0.17 |
$124,187 |
I/I |
739,206 |
1,088,082 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2010-03-15 |
4 |
A |
$0.17 |
$242,164 |
D/D |
1,441,451 |
2,121,760 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2010-01-11 |
4 |
A |
$0.17 |
$20,225 |
I/I |
120,386 |
348,876 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2010-01-11 |
4 |
A |
$0.17 |
$39,439 |
D/D |
234,753 |
680,309 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2009-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
228,490 |
|
- |
|
| SEEL |
Seelos Therapeutics Inc |
EVP Pre-Clinical Business Dev. |
• • – |
2009-12-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
445,556 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
